A. ÖZGÜR Et Al. , "Evaluation of The Efficacy of A New Potential Biosimilar Bevacizumab in The Treatment of Corneal Neovascularization in Rabbits," II. International Dr. Safiye Ali Congress on Multidisciplinary Studies in Health Sciences , 2022
ÖZGÜR, A. Et Al. 2022. Evaluation of The Efficacy of A New Potential Biosimilar Bevacizumab in The Treatment of Corneal Neovascularization in Rabbits. II. International Dr. Safiye Ali Congress on Multidisciplinary Studies in Health Sciences .
ÖZGÜR, A., YEŞİLIRMAK, N., İNAN, M. A., BAĞRIAÇIK, E. Ü., & ÖZMEN, M. C., (2022). Evaluation of The Efficacy of A New Potential Biosimilar Bevacizumab in The Treatment of Corneal Neovascularization in Rabbits . II. International Dr. Safiye Ali Congress on Multidisciplinary Studies in Health Sciences
ÖZGÜR, ARMAĞAN Et Al. "Evaluation of The Efficacy of A New Potential Biosimilar Bevacizumab in The Treatment of Corneal Neovascularization in Rabbits," II. International Dr. Safiye Ali Congress on Multidisciplinary Studies in Health Sciences, 2022
ÖZGÜR, ARMAĞAN Et Al. "Evaluation of The Efficacy of A New Potential Biosimilar Bevacizumab in The Treatment of Corneal Neovascularization in Rabbits." II. International Dr. Safiye Ali Congress on Multidisciplinary Studies in Health Sciences , 2022
ÖZGÜR, A. Et Al. (2022) . "Evaluation of The Efficacy of A New Potential Biosimilar Bevacizumab in The Treatment of Corneal Neovascularization in Rabbits." II. International Dr. Safiye Ali Congress on Multidisciplinary Studies in Health Sciences .
@conferencepaper{conferencepaper, author={ARMAĞAN ÖZGÜR Et Al. }, title={Evaluation of The Efficacy of A New Potential Biosimilar Bevacizumab in The Treatment of Corneal Neovascularization in Rabbits}, congress name={II. International Dr. Safiye Ali Congress on Multidisciplinary Studies in Health Sciences}, city={}, country={}, year={2022}}